Secundum eventus unico globali clinici studii iudicii, nonnulli aegros cum scaena III cancri colonorum, qui chirurgicam tumores et nodorum lymphaticorum resectionem patiuntur, vexillum chemotherapy semestre post chemotherapy non requirunt. E contra, multos aegros humiles periculosos, tres menses chemotherapy non signanter auget ratem cancri recursu et impedire potest nocivum latus effectus, inter nervum damnum ex chemotherapy medicamento oxaliplatina causatum, vel dolor permanens, torpor et tingling.
This is a global trial launched in 2007 on the International Duration Assessment of Adjuvant Chemotherapy (IDEA). Six parallel Phase III trials in 12 countries in North America, Europe and Asia enrolled 12,834 eligible patients. Patients with stage III colonia cancer usually use FOLFOX or CAPOX chemotherapy for standard treatment after surgery. The researchers randomly assigned patients to treatment groups of three or six months.
Results: Three months of chemotherapy is not suitable for all patients. Instead, the data shows that the duration of chemotherapy should be determined based on the combination of drugs used and the individual characteristics of the patient ’s cancer: the degree of tuberculum deposition on the colon wall and the number of lymph nodes that the cancer has spread to. For low-risk patients-those with shallow tumors and affected lymph nodes-treatment with CAPOX for 3 months has been shown to be safe and effective, with little side effects, the same as the progression-free survival (PFS) of six months of treatment. However, in some cases, a six-month course of treatment is better for high-risk patients.
Dr. Anthony lorica et Wayne publica University nisl at doctor dixit in usu, ego applicantur haec nova signa cum aegris ut humilis-periculo colonia cancer quod salvet illos curatio multus of vicis et quoque potest impedire toxicity sex menses effectus chemotherapy. 400,000 de aegris terrarum oxaliplatin consider-fundatur postoperative chemotherapy curatio in solo curandum est, ut haec Inventiones erit ingens impulsum.
